Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Andreeff

Showing results (231-240 of 504) with videos related to

Pageof 51
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2011
Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumorsAnn H Klopp, Yan Zhang, Travis Solley, et al.
British Journal of Haematology|March 28, 2013
Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITDKoichi Takahashi, Hagop Kantarjian, Naveen Pemmaraju, et al.
Oncotarget|April 8, 2017
Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1Kazumasa Sekihara, Kaori Saitoh, Lina Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistanceJing Lu, Ming Tan, Wen-Chien Huang, et al.
Molecular Cancer Therapeutics|May 15, 2020
Combinatorial Inhibition of Focal Adhesion Kinase and BCL-2 Enhances Antileukemia Activity of Venetoclax in Acute Myeloid LeukemiaXiangmeng Wang, Po Yee Mak, Hong Mu, et al.
Haematologica|June 30, 2017
High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemiaZhihong Zeng, Wenbin Liu, Twee Tsao, et al.
Ebiomedicine|May 21, 2019
LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AMLPeter P Ruvolo, Chenyue W Hu, Yihua Qiu, et al.
Blood|December 21, 2006
Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AMLZhihong Zeng, Dos D Sarbassov, Ismael J Samudio, et al.
Transfusion|May 12, 2010
Platelet senescence and phosphatidylserine exposureSwapan Kumar Dasgupta, Eduardo Rios Argaiz, Jose Emmanel Chedid Mercado, et al.
Oncotarget|December 13, 2019
Correction: Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1Kazumasa Sekihara, Kaori Saitoh, Lina Han, et al.
Pageof 51

Showing results (231-240 of 504) with videos related to

Sort By:
Pageof 51
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2011
Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumorsAnn H Klopp, Yan Zhang, Travis Solley, et al.
British Journal of Haematology|March 28, 2013
Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITDKoichi Takahashi, Hagop Kantarjian, Naveen Pemmaraju, et al.
Oncotarget|April 8, 2017
Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1Kazumasa Sekihara, Kaori Saitoh, Lina Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistanceJing Lu, Ming Tan, Wen-Chien Huang, et al.
Molecular Cancer Therapeutics|May 15, 2020
Combinatorial Inhibition of Focal Adhesion Kinase and BCL-2 Enhances Antileukemia Activity of Venetoclax in Acute Myeloid LeukemiaXiangmeng Wang, Po Yee Mak, Hong Mu, et al.
Haematologica|June 30, 2017
High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemiaZhihong Zeng, Wenbin Liu, Twee Tsao, et al.
Ebiomedicine|May 21, 2019
LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AMLPeter P Ruvolo, Chenyue W Hu, Yihua Qiu, et al.
Blood|December 21, 2006
Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AMLZhihong Zeng, Dos D Sarbassov, Ismael J Samudio, et al.
Transfusion|May 12, 2010
Platelet senescence and phosphatidylserine exposureSwapan Kumar Dasgupta, Eduardo Rios Argaiz, Jose Emmanel Chedid Mercado, et al.
Oncotarget|December 13, 2019
Correction: Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1Kazumasa Sekihara, Kaori Saitoh, Lina Han, et al.
Pageof 51